RxDoctor Payments Data

Baokim Bonelli, PA

Physician Assistant · Westerly, RINPI 1841627353

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,096 of the $2,439 with a category attached, or 85.9%. It is spread thinly across 19 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,581 and has fallen 87.4% since, to $199 in 2025.

$2,439in general payments, 2019–2025

Across 98 payments — averaging $24.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$471
  • Lilly USA, LLC$292
  • Novartis$255
  • Amgen$244
  • AbbVie$223
  • Pfizer$198
  • plus $756 from 13 others

What the payments were for

  • Food & beverage$2,09686%
  • Education$34314%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,439 in reported general payments places this provider in the 85th percentile of 481 physician assistant providers in Rhode Island.

See all physician assistant providers in Rhode Island

Medicare billing

Part B allowed, 2024
$83,017
Medicare patients
345
Services billed
1,574

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab11$41,162
Ammonium Lactate182$3,485
Ketoconazole189$2,965
Metronidazole75$2,659
Tacrolimus22$2,649
Calcipotriene15$2,501
Fluorouracil36$2,050
Azelaic Acid28$1,955
Fluocinonide38$1,625
Clobetasol Propionate51$1,492
Tretinoin31$1,416
Mometasone Furoate45$926
Betamethasone Dipropionate21$870
Clindamycin Phosphate18$864
Triamcinolone Acetonide82$626

Paid to pharmacies, not to this prescriber.

Other physician assistant in Westerly

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →